AzTrials
AzTrials

AnxietyNCT03527225

Music of Choice to Decrease Anxiety During Radiation Treatment

A study testing Music in people with Anxiety and Cancer, run by University of Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary hypothesis of the study is that listening to music will reduce anxiety in female cancer patients during the first radiotherapy treatment session. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Anxiety, Cancer
What is being tested?
Music
Could I receive a placebo?
No, everyone receives an active treatment
How many people
135 participants
Where
1 siteUnited States
Study dates
22 Jan 2018to 15 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Scheduled to receive radiotherapy for malignant tumor
  • ECOG Performance Status 0-4
  • Fluent in English Language
  • Inclusion in this study will not be based on race or ethnicity
  • Patients must be deemed able to comply with the treatment plan.
  • Patients must provide study specific informed consent prior to study entry.

Who cannot join

  • Prior history of radiation therapy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Florida Health Cancer Center

    Gainesville, Florida, 32608

Other trials in United States

About this study

Official title: A Randomized Trial of Music to Decrease Anxiety in Women Starting Radiation Therapy for Cancer

The primary hypothesis of the study is that listening to music will reduce anxiety in female cancer patients during the first radiotherapy treatment session.

Read the detailed description

Receiving radiotherapy induces anxiety in at least 1/3 of patients who did not have a previously existing anxiety condition1. Female gender is a positive predictive factor for psychosocial decline during radiotherapy. One-fourth of patients disrupt their planned radiotherapy treatment course due to anxiety. Music therapy has demonstrated effectiveness in reducing anxiety when implemented in other medical settings including mechanical ventilation, burn debridement and venipuncture in pediatric patients. There have been some trials which have found a reduction in anxiety when pre-recorded music along with other relaxation techniques have been implemented during radiotherapy. This trial seeks to investigate the benefit of pre-recorded music alone in reducing anxiety experienced during the first radiotherapy treatment session in female cancer patients.

Conditions
Anxiety, Cancer
Being tested
Music
Keywords
Music Therapy, First Radiotherapy, Anxiety Reduction, Psychosocial Functioning, State - Trait Anxiety Inventory (STAI), Symptom Distress Thermometer (SDT)
Medical subject headings
Anxiety Disorders, Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MusicOther

    The patient's preferred music will be played during the first radiotherapy treatment session from speakers located inside the treatment room. The duration of the music will be 10 to 20 minutes. The music will be turned off at the patient's request if it bothers them. Length of music playing and if the patient requested that it be turned off, will be recorded.

Study groups in NCT03527225
Study groupRoleWhat they receive
MusicExperimentalPatients randomized to the music intervention arm will select a preferred genre of music from an internet based resource.
Receives: Other: Music
No MusicNo interventionThese patient's will have no music playing during the first radiotherapy session.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean change of STAI Score from within 2 hours prior to first RT session to 2 hours post first RT session.

    Percent change in mean anxiety score as measured with the State-Trait Anxiety Inventory (STAI) questionnaire. Assessed by the mean value (pre minus post radiotherapy STAI score) divided by mean pre-treatment score multiplied by 100. A score of 39-40 on each subset suggests clinically significant anxiety.

    Measured: baseline

Secondary outcomes (5)
  1. Mean change of SDT Score from within 2 hours prior to first RT session to 2 hours post first RT session.

    Percentage change in mean anxiety score as measured with the Symptom Distress Thermometer (SDT). Scale of 0 - 10; with 10 being clinically significant distress.

    Measured: baseline

  2. Magnitude change of STAI Score

    The magnitude of change in anxiety score of STAI in "high anxiety" patients (pre-treatment STAI ≥ 40) as a result of listening to music during the first radiotherapy session.

    Measured: baseline

  3. Magnitude change of SDT Score from within 2 hours prior to first RT session to 2 hours post first RT session.

    The magnitude of change in anxiety score of SDT in "high anxiety" patients (pre-treatment SDT ≥ 4) as a result of listening to music during the first radiotherapy session. Scale of 0 - 10; with 10 being clinically significant distress.

    Measured: baseline

  4. STAI "High to Low Score" Change from within 2 hours prior to first RT session to 2 hours post first RT session.

    The number and percentage of patients who drop from a "high" to "low" anxiety level in both intervention groups using STAI scores. A score of 39-40 on each subset suggests clinically significant anxiety.

    Measured: baseline

  5. SDT "High to Low Score" Change from within 2 hours prior to first RT session to 2 hours post first RT session.

    The number and percentage of patients who drop from a "high" to "low" anxiety level in both intervention groups using SDT scores. Scale of 0 - 10; with 10 being clinically significant distress.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2018
  2. Study start22 Jan 2018
  3. Primary completion15 Jan 2020
  4. Study completion15 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Consented, eligible female subjects to be randomized to "Music" or "No Music" to evaluate pre and post treatment anxiety level via STAI and SDT anxiety questionnaire at their first radiotherapy treatment for cancer.
Masking
None (open label)
Enrolment
135 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03527225
Sponsor's protocol ID
IRB201703352
Other IDs
OCR17059
Status last verified
Mar 2020
First submitted
4 May 2018
Last updated
13 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Music in people with Anxiety and Cancer, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean change of STAI Score from within 2 hours prior to first RT session to 2 hours post first RT session. (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in